News

Kelun-Biotech Secures IND Clearance for Groundbreaking ADC SKB518

Kelun-Biotech Secures IND Clearance for Groundbreaking ADC SKB518

Kelun-Biotech Receives IND Approval for SKB518

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has achieved a significant milestone by securing the clearance of its investigational new drug (IND) application for the innovative ADC drug SKB518 from the United States Food and Drug Administration (FDA). This approval marks an exciting advancement for the company in the field of biotechnology.

Overview of the IND Clearance Process

The IND clearance is vital for initiating clinical studies that explore how a drug works in humans. Following rigorous evaluation, the FDA has deemed SKB518 suitable for further development. The clearance opens doors for the company to move forward with its clinical trials and deepen its research into this groundbreaking treatment option.

Previous Approvals

Prior to this FDA clearance, Kelun-Biotech made significant strides in obtaining a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for SKB518, which is specifically aimed at treating advanced solid tumors.

About the Innovative Drug SKB518

SKB518 is distinguished as a novel antibody-drug conjugate (ADC) that combines the potent properties of targeted therapy with the benefits of traditional chemotherapy. The drug was developed using the cutting-edge OptiDC™ platform, which allows for maximum effectiveness while minimizing side effects. Preclinical studies have shown encouraging results, emphasizing the drug’s potential as a first-in-class therapy.

Mechanism of Action and Benefits

The efficacy and safety profile of SKB518 positions it as a promising candidate for treating patients with advanced solid tumors. By selectively targeting cancer cells, SKB518 aims to improve treatment outcomes while maintaining patient quality of life.

About Kelun-Biotech

Kelun-Biotech is a dynamic and innovative subsidiary of Kelun Pharmaceutical, dedicated to the research and development of groundbreaking biological and small molecule drugs. The company focuses on crucial therapeutic areas, including solid tumors, autoimmune disorders, inflammatory conditions, and metabolic diseases. With a commitment to addressing unmet medical needs, Kelun-Biotech is establishing a globalized drug development platform designed to facilitate the delivery of life-saving therapies both in its home market and worldwide.

Current Projects and Future Goals

As of now, Kelun-Biotech is managing over 30 key innovative drug development projects, showcasing its robust pipeline. Among these, three projects have received market approval, one is in the NDA stage, and more than ten are currently in clinical stages. With one of the world’s leading proprietary ADC platforms, OptiDC™, the company is set to remain at the forefront of cancer treatment innovations.

Frequently Asked Questions

What is SKB518?

SKB518 is a novel antibody-drug conjugate developed by Kelun-Biotech aimed at treating advanced solid tumors, with promising efficacy and safety profiles.

When was the IND clearance granted?

The IND approval allows Kelun-Biotech to begin clinical trials for SKB518, reflecting substantial regulatory support for its development.

What therapeutic areas does Kelun-Biotech focus on?

Kelun-Biotech's projects prioritize solid tumors, autoimmune diseases, inflammation, and metabolic disorders, targeting significant health issues globally.

How many innovative drug projects is Kelun-Biotech managing?

The company is actively involved in over 30 innovative drug projects, showcasing its expertise and commitment to drug development.

What platform does Kelun-Biotech use for ADC development?

Kelun-Biotech utilizes the OptiDC™ platform for its ADC projects to enhance the effectiveness and safety of its cancer therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

K-Jeonnam Gim Debuts on Amazon: Korean Seaweed Arrives

Updated Category News Views 114

Korean Seaweed Ventures to the US Market Alright, folks, here's a twist for your snack drawer—Korean seaweed making waves right on Amazon's virtual shelves! Shinan 1004 Seaweed Co. is shaking things up with their brand spankin' new K-Jeonnam Gim. This ain't just any old sea greens we're talking about. We're dealing with crispy, roasted sheets bursting with savory, nutty...

Continue Reading
Surfshark's No-Logs Policy Gets KPMG Backing

Updated Category News Views 168

Surfshark's Commitment to Privacy Pardon my grizzled voice, but in today's world, where digital privacy often feels like a myth, having a VPN that sticks to its guns about not keeping logs is rare enough to make you look twice. Well, here comes Surfshark, loudly touting yet another seal of approval from one of the Big Four—KPMG. Not the first time for these folks, but...

Continue Reading
Finding the Right Auto Insurance: What to Consider

Updated Category News Views 188

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Continue Reading
Schools Reimagine Yearbooks with Interactive Archives

Updated Category News Views 80

Revamping School Memories for the Tech Age In a world where every facet of life is digitally chronicled, it's about time schools got on board the archival train in a dynamic way. That's where Rocket Alumni Solutions steps in, breathing fresh life into those dust-gathering yearbooks and sepia-toned photos. Tackling History Collection by Collection Think you can throw a...

Continue Reading
Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 58

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
$10,000 Boost Fuels Nichols College's Archaeological Quest

Updated Category News Views 178

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 98

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
BULL Faces Class Action After Regulatory Fines

Updated Category News Views 109

Webull's Financial Quake Shakes Investors You don't expect to wake up to news of a stock in freefall, but here we are with Webull (NASDAQ:BULL) cratering after some rough compliance problems came to light. On November 5, 2026, Webull's stock tumbled nearly 11% thanks to FINRA slapping them with a $4.2 million fine for failing to keep their anti-money laundering (AML) and...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Innovative Rotating Kitchen Organizer Up for Licensing

Updated Category News Views 87

Dusting Off the Corners: A Fresh Spin on Kitchen Storage Just when you think there's nothing new under the sun when it comes to storing your kitchen gadgets, here comes an invention straight out of Billings, Montana. It's called The Rotating Kitchen Organizer, a nifty contraption that's all set to turn those dead corners into prime real estate. How many times have we...

Continue Reading

Top 5 Most Recently Viewed Articles

Sital K. Mody Joins First Horizon's Board of Directors

Updated Category News Views 418

First Horizon Welcomes Sital K. Mody to Its Board First Horizon Corporation (NYSE: FHN) is excited to announce the election of Sital K. Mody as an independent director to its Board of Directors and First Horizon Bank Board. With a wealth of experience in the energy sector and a deep understanding of operational excellence, Mody is expected to contribute significantly to...

Continue Reading
Sky Labs' Apollon Device Achieves CES 2025 Innovation Honor

Updated Category News Views 298

Sky Labs Receives CES 2025 Innovation Award for Apollon Sky Labs recently made headlines with their innovative wearable technology, the Apollon device, which has been recognized as an Honoree in the Artificial Intelligence category at the prestigious CES 2025 Innovation Awards. This honor is awarded by the Consumer Technology Association (CTA) and signifies the remarkable...

Continue Reading
Navigating the Markets: Insights on Key Investments

Updated Category News Views 137

Understanding Market Trends and Key Stocks Good Morning Traders! As we embark on this week, the economic landscape presents a rather light start. Although the calendar is not burdened with high-impact data initially, the market holds potential for movement as we approach critical events. Today, manufacturing data is expected to be released, providing insight into the...

Continue Reading
OPENLANE to Release Earnings Results and Conference Details

Updated Category News Views 134

OPENLANE to Announce Third Quarter Financial Results OPENLANE, Inc. (NYSE: KAR), a prominent platform for digital marketplaces in the wholesale used vehicle sector, is set to unveil its financial results for the third quarter of 2025. This announcement is scheduled to occur before market hours on a Wednesday in early November. Conference Call and Webcast Information In...

Continue Reading
Kempinski Hotels and BTG Hotels Unite to Enhance Luxury Travel

Updated Category News Views 230

Kempinski Hotels and BTG Hotels Collaboration Kempinski Hotels is excited to announce an extended strategic partnership with BTG Hotels, highlighting their dedication to luxury hospitality in China. For over 30 years, both companies have played significant roles in shaping the luxury hotel landscape, and this new chapter promises to solidify their status further. Goals of...

Continue Reading